BioSpace News Archive

Phillips-Medisize has teamed with GlucoModicum, an innovative medtech company based in Finland, to design and eventually commercialize a proprietary non-invasive, wearable device that removes technology and patient-care roadblocks to continuous glucose monitoring (CGM).

NeuroSigma today announced approval of the Monarch eTNS System by Singapore’s Health Sciences Authority (HSA), the national body that regulates medical devices, therapeutics, and other healthcare products.

Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic low back pain, announced that Anthem Blue Cross and Blue Shield has established favorable coverage for the Intracept® Procedure.

ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect patients from severe allergic reactions that could lead to anaphylaxis, announced today the publication of its full pharmacokinetic and pharmacodynamic results from one of its four primary registration studies of neffy (epinephrine nasal spray) in the Journal of Allergy and Clinical Immunology (JACI).

Centinel Spine®, LLC announced that more than 250,000 prodisc devices have been implanted worldwide.* The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany.

Ocutrx Technologies, Inc. announced it has hired Jeff Gilbert as Chief Operating Officer for its subsidiary, Spectrum Advanced Manufacturing Technologies, Inc., a long-time microelectronics and FDA certified manufacturing facility located in Colorado Springs, CO.

Trace Medical, the national leader in advanced respiratory rentals and biomedical services, has announced a long-term distribution agreement with Outset Medical to rent the Tablo® Hemodialysis System to Home Medical Equipment (HME) providers.

Trinity Biotech plc, a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced the Company’s results for the quarter ended June 30, 2023.

SurGenTec, a privately held medical device company focusing on spine and orthopedic technologies, proudly announces FDA clearance for TiLink-P, a first-of-its-kind, minimally-invasive implant that offers hope for individuals suffering from chronic sacroiliac (SI) joint pain.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.